CJC-1295 + Ipamorelin is a research-grade peptide combination designed to support the investigation of growth hormone regulatory pathways through complementary mechanisms. CJC-1295 acts as a Growth Hormone Releasing Hormone (GHRH) analog, stimulating the GHRH receptor to model hypothalamic signaling and investigate GH synthesis and pulsatility. Ipamorelin, a selective Growth Hormone Releasing Peptide (GHRP), engages the ghrelin receptor (GHSR-1a) with high specificity, enabling precise analysis of downstream GH release and pituitary activation.
When used together in controlled experimental models, this dual-agonist combination allows researchers to study the synergistic interaction between GHRH and GHSR pathways. This provides a useful tool for examining somatotropic axis modulation, GH pulse frequency, endocrine feedback loops, and comparative effects on metabolic regulation.
Research Use Only
This peptide combination is intended strictly for laboratory and in vitro research applications. CJC-1295 + Ipamorelin is NOT for human use, veterinary use, diagnostic procedures, or therapeutic applications. Must be handled only by qualified professionals in a controlled research environment.
Product Care:
Store lyophilized material in a cool, dry environment protected from light and moisture.
If reconstituted, refrigerate at 2–8°C.
For extended long-term storage, freezing at –20°C is recommended to preserve peptide stability and integrity.
Reviews
There are no reviews yet.